Department of Pharmacology, Toxicology and Clinical Pharmacology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Romania.
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10812-10818. doi: 10.26355/eurrev_202010_23443.
H2 receptors' antagonists (H2RA) are widely used drugs and they are generally well-tolerated. Ranitidine hypersensitivity reactions (HR) are rarely reported. The article emphasizes the importance of recognizing ranitidine as a cause of anaphylaxis and the advantages and limits of allergological evaluation to establish a positive diagnose. We reviewed a series of published cases of ranitidine-induced hypersensitivity reactions, starting from a clinical case presentation. Moreover, we analyzed the ranitidine related adverse events in the Eudravigilance European database of adverse reactions. Most of the allergic reactions induced by ranitidine are type I HR with immediate onset after exposure, with variable clinical presentation. But in a few cases, there were also described delayed reactions, some after occupational exposure. The article underlines the importance of allergy evaluation to avoid future contact with the drug to reduce the risk of more severe reactions. The suspected reactions should be reported, allowing pharmacovigilance systems to analyse them and to establish further recommendations for clinicians.
H2 受体拮抗剂(H2RA)是广泛使用的药物,通常具有良好的耐受性。雷尼替丁过敏反应(HR)很少见。本文强调了认识到雷尼替丁是过敏反应的原因的重要性,以及过敏评估的优点和局限性,以建立阳性诊断。我们从临床病例介绍开始,回顾了一系列已发表的雷尼替丁引起的过敏反应病例。此外,我们分析了欧洲不良事件警戒数据库中与雷尼替丁相关的不良事件。雷尼替丁引起的大多数过敏反应是 I 型 HR,接触后立即发生,临床表现多样。但在少数情况下,也有描述延迟反应,有些是职业接触后发生的。本文强调了过敏评估的重要性,以避免未来接触该药物,从而降低更严重反应的风险。应报告疑似反应,以便药物警戒系统对其进行分析,并为临床医生制定进一步的建议。